EMEA Marketing Recommendation May Give European Alli A Boost

The European Medicines Agency's support for a marketing authorization for orlistat in Europe signals a key step in GlaxoSmithKline's plan to launch a nonprescription version of the weight-loss drug in that part of the world, the company says